{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:31:10Z","timestamp":1761611470984},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.lungcan.2019.01.018","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T07:23:45Z","timestamp":1549005825000},"page":"156-158","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis"],"prefix":"10.1016","volume":"130","author":[{"given":"N.","family":"de Rouw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Croes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Posthuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.E.","family":"Agterhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.A.O.","family":"Schoenmaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J","family":"Derijks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.M.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"ter Heine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lungcan.2019.01.018_bib0005","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00280-005-0036-1","article-title":"Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients","volume":"57","author":"Latz","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.lungcan.2019.01.018_bib0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00280-005-0035-2","article-title":"Clinical application of a semimechanistic-physiologic population PK\/PD model for neutropenia following pemetrexed therapy","volume":"57","author":"Latz","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.lungcan.2019.01.018_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00408-008-9123-5","article-title":"Lung cancer and renal insufficiency: prevalence and anticancer drug issues","volume":"187","author":"Launay-Vacher","year":"2009","journal-title":"Lung"},{"key":"10.1016\/j.lungcan.2019.01.018_bib0020","article-title":"Development and validation of a limited sampling strategy for pemetrexed therapeutic drug monitoring and research purposes","author":"de Rouw","year":"2018","journal-title":"3rd International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD)"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500219303058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500219303058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T04:05:43Z","timestamp":1555041943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500219303058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":4,"alternative-id":["S0169500219303058"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2019.01.018","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2019.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}